Circulation (2008) 117:234050
A November 2025 study found that GLP-1 receptor antagonist (RA) use, including semaglutide, was associated with reduced rates of urinary retention and urinary tract infections (UTIs) in non-diabetic women receiving treatment for overactive bladder syndrome
Does the sulfur smell of glutathione mean it is bad for my gut
642 In a multicenter, randomized, double-blind, placebo-controlled phase-3 clinical trial conducted in China, acetyllevocarnitine hydrochloride treatment for 24 weeks significantly improved symptoms and somatosensory symptoms in patients with DPN, with a treatment effect of 65% higher than placebo
His background allows careful oversight of intravenous therapies with attention to safety, dosing, and individual biochemical variation
Portman OW, Alexander M